Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
3,900
Frequently Asked Questions
What is Market Cap of Insulet Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Insulet Corporation market cap is $24.53B.
What is the 52-week high for Insulet Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Insulet Corporation 52 week high is $350.00 as of September 08, 2025.
What is the 52-week low for Insulet Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Insulet Corporation 52 week low is $216.00 as of September 08, 2025.
What is Insulet Corporation stock price today?
Insulet Corporation stock price today is $348.43.
What was Insulet Corporation stock price yesterday?
Insulet Corporation stock price yesterday was $346.47.
What is the PE ratio of Insulet Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Insulet Corporation’s P/E ratio is 106.04.
What is the Price-to-Book ratio of Insulet Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Insulet Corporation P/B ratio is 16.7655.
What is the 50-day moving average of Insulet Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Insulet Corporation 50-day moving average is $307.19.
